Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’

Detalles Bibliográficos
Autores principales: Romach, EH, Posobiec, LM, Bloomer, JC, Zamek-Gliszczynski, MJ, Stanislaus, DJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050848/
https://www.ncbi.nlm.nih.gov/pubmed/33857900
http://dx.doi.org/10.1016/j.ebiom.2021.103335
_version_ 1783679649754120192
author Romach, EH
Posobiec, LM
Bloomer, JC
Zamek-Gliszczynski, MJ
Stanislaus, DJ
author_facet Romach, EH
Posobiec, LM
Bloomer, JC
Zamek-Gliszczynski, MJ
Stanislaus, DJ
author_sort Romach, EH
collection PubMed
description
format Online
Article
Text
id pubmed-8050848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80508482021-04-21 Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’ Romach, EH Posobiec, LM Bloomer, JC Zamek-Gliszczynski, MJ Stanislaus, DJ EBioMedicine Letter Elsevier 2021-04-12 /pmc/articles/PMC8050848/ /pubmed/33857900 http://dx.doi.org/10.1016/j.ebiom.2021.103335 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter
Romach, EH
Posobiec, LM
Bloomer, JC
Zamek-Gliszczynski, MJ
Stanislaus, DJ
Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_full Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_fullStr Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_full_unstemmed Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_short Letter to the editor in re: Mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
title_sort letter to the editor in re: mohan et al., 2020 ‘dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels’
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050848/
https://www.ncbi.nlm.nih.gov/pubmed/33857900
http://dx.doi.org/10.1016/j.ebiom.2021.103335
work_keys_str_mv AT romacheh lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels
AT posobieclm lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels
AT bloomerjc lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels
AT zamekgliszczynskimj lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels
AT stanislausdj lettertotheeditorinremohanetal2020dolutegravirinpregnantmiceisassociatedwithincreasedratesoffetaldefectsattherapeuticbutnotatsupratherapeuticlevels

Ejemplares similares